Lung cancer staging and surgery

December 2007
Thorax;Dec2007 Supp, Vol. 62, pA40
Academic Journal
The article presents abstracts on medical topics which include the impact of fluoro-deoxy-glucose-positron emission tomography (PET) on the prevalence of benign lesions at thoracotomy, the effect of preoperative computed tomography-PET on the surgical management of the solitary pulmonary nodule and contraindication of surgery for patients with small cell lung cancer and clinical N2 disease.


Related Articles

  • Surgery.  // Current Medical Literature: Lung Cancer;2010, Vol. 4 Issue 2, p53 

    The article presents information on studies on the use of surgery for lung cancer. It explains that the use of preoperative chemo-therapy on overall survival (OS) for stage II non-cell-small cell lung cancer (NCSLC) needs more statistically significant findings. It cites trials on different...

  • Multimodality approach to mediastinal staging in non-small cell lung cancer. Faults and benefits of PET-CT: a randomised trial. Barbara M Fischer // Thorax;Apr2011, Vol. 66 Issue 4, p294 

    BACKGROUND: Correct mediastinal staging is a cornerstone in the treatment of patients with non-small cell lung cancer. A large range of methods is available for this purpose, making the process of adequate staging complex. The objective of this study was to describe faults and benefits of...

  • PET staging may reduce SCLC treatment costs.  // PharmacoEconomics & Outcomes News;5/26/2012, Issue 654, p6 

    The article discusses the effectiveness of positron emission tomography (PET) compared with conventional staging in the treatment of small-cell lung cancer, referencing a study by J. D. Ruben and colleagues published on the April 24, 2012 issue of the "Journal of Thoracic Oncology."

  • Positron emission tomography may underestimate the extent of thoracic disease in lung cancer patients. Carnochan, Fiona M.; Walker, William S. // European Journal of Cardio-Thoracic Surgery;May2009, Vol. 35 Issue 5, p781 

    Abstract: Objective: Although widely utilised in the staging of lung cancer various studies have questioned whether the accuracy of this staging modality is sufficient to replace conventional invasive staging techniques. We have therefore reviewed our experience in order to assess the accuracy...

  • FDG-PET imaging for the staging and follow-up of small cell lung cancer. Schumacher, Tilmann; Brink, Ingo; Mix, Michael; Reinhardt, Michael; Herget, Georg; Digel, Werner; Henke, Michael; Moser, Ernst; Nitzsche, Egbert // European Journal of Nuclear Medicine;2001, Vol. 28 Issue 4, p483 

    Abstract. The staging procedures for small cell lung cancer do not differ appreciably from those for other forms of lung cancer. For practical purposes, the TNM stages are usually collapsed into a simple binary classification: limited disease and extensive disease. This study was performed to...

  • Mediastinal staging of lung cancer with 2-[fluorine-18]-fluoro-2-deoxy-D-glucose positron emission tomography and a dual-head coincidence gamma camera. Zimny, Michael; Hochstenbag, Monique; Lamers, Rob; Reinartz, Patrick; Cremerius, Uwe; ten Velde, Guul; Buell, Udalrich // European Radiology;Apr2003, Vol. 13 Issue 4, p740 

    The aims of the present study were (a) to evaluate mediastinal staging in patients with lung cancer with 2-[fluorine-18]-fluoro-2-deoxy-D-glucose (FDG) using a coincidence gamma camera (hybrid PET) in comparison with dedicated positron emission tomography (PET) and computed tomography (CT), and...

  • Rola pozytonowej tomografii emisyjnej (PET) w planowaniu radioterapii. Cytawa, Wojciech // Polish Oncology / Onkologia Polska;2012, Vol. 15 Issue 3, p103 

    The effectiveness of radiotherapy is highly dependent on precise target volume delineation. Apart from computed tomography which is a "gold standard" in radiotherapy planning,: other imaging modalities, such as positron emission tomography (PET), begin to play an important role in this process....

  • Role of positron emission tomography in mediastinal lymphatic staging of non-small cell lung cancer. Melek, Huseyin; Gunluoglu, Mehmet Zeki; Demir, Adalet; Akin, Hasan; Olcmen, Aysun; Dincer, Seyyit Ibrahim // European Journal of Cardio-Thoracic Surgery;Feb2008, Vol. 33 Issue 2, p294 

    Abstract: Objective: Positron emission tomography (PET) is used increasingly in staging of non-small cell lung cancer (NSCLC) as a non-invasive tool. The role of the PET in mediastinal lymphatic staging of NSCLC is not clear. We aimed to demonstrate the efficacy of PET in determining mediastinal...

  • Measurement of tumor volume by PET to evaluate prognosis in patients with advanced non-small cell lung cancer treated by non-surgical therapy. Hongjiang Yan; Renben Wang; Fen Zhao; Kunli Zhu; Shumei Jiang; Wei Zhao; Rui Feng // Acta Radiologica;Jul2011, Vol. 52 Issue 6, p646 

    Background: Patients with advanced non-small cell lung cancer (NSCLC) seem to have disparity in prognosis. Accurate prediction of prognosis could be useful in the future to predict individual risk and to develop more aggressive or alternative treatment strategies. Purpose: To evaluate the...

  • Non-small Cell Lung Cancer With Unsuspected Distant Metastasis To the Kidney Seen on PET/CT. Barry-Brooks, Marilyn; Yoo, Don C.; Chaump, Michael; Noto, Richard B. // Medicine & Health Rhode Island;May2012, Vol. 95 Issue 5, p144 

    The article presents a case study of a 72-year-old man diagnosed with Non Small Cell Lung Cancer (NSCLC) addicted to smoking complained about hoarseness during his physical examination. The Computed Tomography (CT) scan of his chest showed five centimeter left upper lobe mass invading the...


Read the Article


Sign out of this library

Other Topics